12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, health care stocks saw significant movements. Geron (GERN) led the gainers with a 90.8% increase, while Kineta (KA) experienced the largest drop among the losers, declining by 8.3%. Notably, Akebia Therapeutics (AKBA) rose by 8.02% following its Q4 earnings report.
March 14, 2024 | 9:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akebia Therapeutics stock rose 8.02% to $1.48 after its Q4 earnings report, with a market cap of $278.7 million.
The positive reaction to AKBA's Q4 earnings report suggests the results were favorable, leading to increased investor interest.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Geron stock surged 90.8% in after-market trading, reaching $3.34 with a market cap of $1.8 billion.
The significant surge in GERN's stock price indicates strong investor confidence, potentially due to positive developments or expectations.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Kineta stock declined by 8.3% to $0.56, with a market value of their outstanding shares at $5.8 million.
The decline in KA's stock price suggests negative sentiment or disappointing news affecting investor confidence.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100